
- Remove this product from my favorite's list.
- Add this product to my list of favorites.
Products
Newsletter
![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
Background
It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.
Source
The mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Spike RBD. The antibody is specific against the Omicron (B.1.1.529/BA.1) variant of SARS-CoV-2, and has no binding with the spike RBD of the wild type virus and other viral lineages.
Isotype
Mouse IgG/kappa
Specificity
This product is a specific antibody against Spike RBD of Omicron (B.1.1.529/BA.1) variant of SARS-CoV-2. Cross-reactivity with Spike protein RBD domain of other coronaviruses, including SARS-CoV, MERS-CoV, HCoV-229E, HCoV-NL63, HCoV-OC43 and HCoV-HKU1, has not been tested.
Purity
>95% as determined by SDS-PAGE.
Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally Trehalose are added as protectants before lyophilization.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Bioactivity
Please refer to product data sheet.
Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
Olearo, Radmanesh, Felber et al. (2022) "Anti-SARS-CoV-2 antibodies in breast milk during lactation after infection or vaccination: A cohort study" J Reprod Immunol 153, 103685
Okada, Ikeda-Ishizaka, Ono et al. (2022) "Establishment of Neutralizing Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 by the Screening with Exosomes Expressing the Viral Spike Protein" , Monoclon Antib Immunodiagn Immunother 41 (4), 173-180
Meira, Silva, Santos et al. (2022) "Diagnostic Performance of Three ELISAs for Detection of Antibodies against SARS-CoV-2 in Human Samples" ScientificWorldJournal , 7754329
Recombinant SARS-CoV-2 (COVID-19) S1 protein, His Tag (MALS verified), 100µg - 494,00 €
Recombinant Biotinylated SARS-CoV-2 (COVID-19) S protein RBD, His,Avitag™ (MALS verified), 25µg - 494,00 €
Recombinant Biotinylated SARS-CoV-2 (COVID-19) S1 protein, His,Avitag™ (MALS verified), 25µg - 494,00 €
Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid protein, His Tag, 100µg - 520,00 €
Recombinant SARS-CoV-2 Spike RBD, His Tag (BA.2/Omicron) (MALS verified), 100µg - 480,00 €
Recombinant Biotinylated SARS-CoV-2 Spike RBD, His,Avitag™ (BA.2/Omicron) (MALS verified), 25 µg - 456,00 €
Welcome Login
Contact us
Follow us